Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Belatacept may be a promising treatment for alopecia areata.

New treatments for hair loss show promise with advanced therapies and better targeting.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Anti-TNF therapy can cause hair loss and skin issues.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

New therapies for rare skin diseases show promise but need more research.

Denosumab may cause alopecia areata.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Microneedles show promise for improving hair regrowth in alopecia.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.